⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX LAWSUIT ALERT: MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses
globenewswire.com
MLTX
SueWallSt Podcast Series Launches With Focus on MoonLake Immunotherapeutics (MLTX) Fraud Allegations
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
MLTX
Pomerantz LLP Notifies Shareholders of Class Action Filing Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Shareholders SueWallSt in New Class Action Against MoonLake Immunotherapeutics - Act Now
accessnewswire.com
MLTX
Contact The Gross Law Firm by December 15, 2025 Deadline to Join Class Action Against MoonLake Immunotherapeutics(MLTX)
globenewswire.com
MLTX
MLTX STOCK NEWS: MoonLake Immunotherapeutics Drug Trial Results Trigger Securities Class Action - Contact BFA Law by December 15
accessnewswire.com
MLTX
TSLA
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
newsfilecorp.com
MLTX
MLTX 1-WEEK DEADLINE ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
globenewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
prnewswire.com
MLTX